Seeking for a Biotech/Pharma Job in U.S ? You are at the right place then. Before selecting the company in which you want to work, you must be aware of the regions where maximum cluster of companies & Research institutes are present. This will minimize your effort of job search. Language, familiarity with western culture and a willingness to move are the key reasons Indians are getting more top jobs in the US.
Below we present a listing of seven regions in the U.S. that hold promise for securing a biopharma job based on the size of their clusters of research universities, businesses, and nonprofit research institutes, where you can apply.
Hot Spots for Biotech Jobs in U.S
To generate its list of the top U.S. regions in which to secure a biotech job was created by analyzing the most frequently regions that are cited in Biotechnology and pharmaceutical job listings. Lets have a look :
New York
NY tops the list. While metro New York has long enjoyed access to capital and top-flight research hospitals, the Big Apple has taken a bigger bite of biopharma since the 2007–09 recession. Reasons include the long fractious community of nonprofit teaching hospitals and research institutions finally uniting behind initiatives like the New York Genome Center; the construction of new facilities, notably the Alexandria Center™ for Life Science on Manhattan’s East Side, with pharma giants such as Roche and Eli Lilly’s ImClone subsidiary filling the space; and the solid support of business and political leaders led by Mayor Michael Bloomberg, who leaves office at year’s end. The wide-ranging New York region includes a mix of legacy pharmas and biotechs in northern and central New Jersey.
Biopharma Companies in New York :
Perrigo
Bristol-Myers Squibb
Enzo Life Sciences
Invitrogen (Life Technologies)
ICON Clinical Research
Pfizer
Synergy Pharmaceuticals
AMRI
Boston/Cambridge, MA
Long the East Coast’s biggest biopharma cluster, Boston/Cambridge expects several biopharma giants to complete their facility expansions over the next year, creating hundreds of new jobs—and accelerating what has been near-flat job growth since the 2007–09 recession, in part due to increased activity in neighboring New York. Vertex Pharmaceuticals has opened its new headquarters at Fan Pier on the South Boston waterfront, while Biogen Idec, Novartis, and Pfizer, are building new Cambridge, MA, sites. Yet Boston/Cambridge retains numerous advantages, from its critical mass of universities, research institutions, and companies, to state support through the $1 billion Massachusetts Life Sciences Initiative, enacted in 2008 before the financial crisis and overseen by the quasi-public Massachusetts Life Sciences Center.
Bio / pharma Companies in Boston 
Quanticate
Merck
Integra Life Sciences
Abcam
Alexion Pharmaceuticals
Aura Biosciences
Bayer Diagnostics
Biogen
MedGenome
San Francisco
The nation’s largest biocluster began a generation ago in South San Francisco with a scrappy startup named Genentech. And while the San Francisco Bay Area has been challenged in recent years by cutbacks at its largest businesses and its high cost of doing business, as several biopharma CEOs have lamented, the region is also enjoying the IPO boom of the past year, as several homegrown biotechs have gone public including Five Prime Therapeutics and KaloBio, OncoMed Pharmaceuticals, and Portola Pharmaceuticals.
Biotech / Pharma Comapanies in San Fransico 
10X Genomics
23 and me
Abbott
Affymetrix
Agilent
Bayer
Biorad
Genentech (Roche)
Philadelphia
Greater Philadelphia enjoys proximity to the heritage pharma giants that arose in the region and Pennsylvania’s neighbors to the south (Delaware) and north (New Jersey). But the region has also jumpstarted numerous biotechs over the past generation, both through the University City Science Center and, more recently, as spinouts from its universities, research institutes, and research hospitals.
Biopharma Companies in Philadelphia :
GlaxoSmithKline
Integral Molecular
PRA Health Sciences
Rosetta Genomics
WuXi Apptec
Xenogenics Corporation
Adaptimmune
Chicago
The Windy City might well be called the BIO city, having hosted the Biotechnology Industry Organization’s annual conventions in 2010 and this year. The April 22–25 convention gave Chicago and suburban Chicagoland a chance to trumpet several initiatives—led by a planned new downtown Bioscience & Pharmaceutical Industry Commercialization and Innovation Center. The center will be filled in part by the consortium Chicago Innovation Mentors, whose partners include Northwestern University, the University of Chicago, University of Illinois, Rehabilitation Institute of Chicago, Argonne Laboratories, and iBIO Institute's PROPEL Center, which assists life-science startups. The University of Chicago has expanded its biotech presence, while the 560-acre Illinois Medical District has grown to more than 80 health, education, public safety, social service, and technology organizations, two medical universities, and four major medical centers. The region’s industry anchors are established pharmas that are either based in suburbs of Chicago, such as Abbott Laboratories and its AbbVie prescription-drug spinoff, or have U.S. headquarters in the region, such as Japanese drug developers Astellas Pharma and Takeda Pharmaceutical.
Biopharma Companies in Chicago :
AbbVie
Abbott
Johnson & Johnson
PSC Biotech
Amgen
Baxter
Covance
Takeda Pharmaceutical
Allergan
Lonza
Teva Pharmaceuticals
Washington, DC (includes parts of Maryland and Virginia) :
The region that NIH and FDA call home has had some adjusting to do in recent years, as two if its most successful biotechs that began as homegrown startups got bought by pharma giants—MedImmune in 2007 (by AstraZeneca for $15.6 billion) and Human Genome Sciences (HGS; by GlaxoSmithKline for $3 billion). In Virginia, state officials have exempted from state income tax the long-term capital gains of investors in early-stage biotechs through June 30, 2015, and increased Angel Investment Tax Credit funding in February from $4 million to $4.5 million this year and $5 million in 2014, while the Virginia Biotechnology Research Park announced plans in July for an $18 million expansion that will add up to 50,000 square feet of new office and lab space to the campus.
Biopharma Companies in Washington, DC
Nova Biomedical Corporation
Astra Zeneca
MedImmune
Sterling Life Sciences
United Therapeutics Corporation
Covance
Qiagen
INC Research
San Diego
A recent report suggests evidence that the San Diego biotech scene is going strong. Released in December 2011 the Life Sciences Cluster Report by Jones Lang LaSalle rates San Diego #7 in the global biotech clusters. Ranking in the top 10 for funding – third in VC and sixth for NIH funding – it seems that the money is rolling in for San Diego. The 97-page study says San Diego’s dense concentration of Incubator and start-ups is expected to continue growth in the near future.Each of the submarkets reviewed – UTC, Torrey Pines, Sorrento Mesa, and Sorrento Valley – experienced growth in 2011, aside from Sorrento Mesa being almost completely leased. The report forecasts continued recovery in rents, vacancies tightening and, due to a lack of new development, re-positioning of older properties to meet demands for higher quality facilities, particularly in Sorrento Mesa.
Biopharma Companies in San Diego :
Abeomics
Accelrys
Acris Antibodies
Genetex
Trius Therapeutics
Life Technologies
Halozyme Therapeutics, Inc.
Illumina
Vertex Pharmaceuticals
Seattle
A decade ago, it looked like Seattle was taxiing on the proverbial runway for takeoff into a top-tier biopharma cluster. Since then, the region’s corporate biopharma presence has struggled for reasons ranging from M&A activity (Merck snapped up the Rosetta Research Center, then shut it down) to rivals and price pressures (Dendreon has struggled with the $93,000 price of prostate cancer treatment Provenge, plus competition from prostate cancer drugs by Johnson & Johnson and Medivation).
Biopharma Companies in Seatle :
Adaptive Biotechnologies
Gilead
Immusoft
LabConnect
LifeSpan Biosciences
Novo Nordisk
PAI Life Sciences
Presage Biosciences
Soon we will be publishing reports on Job outside U.S | Stay Connected !